Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      Government notifies Drugs and Clinical Trial Rules 2019

      Government notifies Drugs and Clinical Trial Rules 2019

      Meghna A Singhania26 March 2019 9:31 AM IST
      The new rules will ensure patient safety, as they would be enlisted for trials with informed consent. The ethics committee will monitor the trials and...
      Radiologists find new use of Amazon Alexa, Google Home during Medical Procedures

      Radiologists find new use of Amazon Alexa, Google Home during Medical Procedures

      Meghna A Singhania25 March 2019 12:36 PM IST
      Smart speakers, such as the Amazon Echo and Google Home, offer a conversational voice interface that allows interventional radiology (IR) physicians...
      Interim Relief: Delhi High Court stays ban on e-cigarettes,Vapes,E-Sheesha till May 17, 2019

      Interim Relief: Delhi High Court stays ban on e-cigarettes,Vapes,E-Sheesha till May 17, 2019

      Meghna A Singhania24 March 2019 11:00 AM IST
      Delhi High Court observed that Electronic Nicotine Delivery Systems(ENDS) including e cigarettes cannot be regarded as 'drugs'. New Delhi: Granting...
      NATHEALTH appoints Manipal Health Enterprise Chairman Dr Sudarshan Ballal as president for 2019-20

      NATHEALTH appoints Manipal Health Enterprise Chairman Dr Sudarshan Ballal as president for 2019-20

      Meghna A Singhania23 March 2019 1:31 PM IST
      Manipal Health ChairmanSudarshan Ballal succeeds Fortis Healthcare's Daljit Singh as the president, the Healthcare Federation of India (NATHEALTH)...
      Stop promotion of tobacco brands in Filmfare Awards: Delhi Government Official to Centre

      Stop promotion of tobacco brands in Filmfare Awards: Delhi Government Official to Centre

      Meghna A Singhania23 March 2019 9:30 AM IST
      Additional Director in Delhi Health Department Dr S K Arora, who was earlier heading Delhi State Tobacco Control cell, wrote the letters in his...
      NPPA fixes retail price of Certain Hard Gelatin Capsules; Check Details

      NPPA fixes retail price of Certain Hard Gelatin Capsules; Check Details

      Meghna A Singhania22 March 2019 3:25 PM IST
      New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of hard...
      Refix Ceiling Price of Torrent pharmas Trilosar 6.25, 12.5 : DoP directs NPPA

      Refix Ceiling Price of Torrent pharmas Trilosar 6.25, 12.5 : DoP directs NPPA

      Meghna A Singhania21 March 2019 10:30 AM IST
      New Delhi: The Department of Pharmaceuticals (DoP) has accepted the review petition of Torrent Pharmaceutical against price fixation of formulations...
      SEBI bars Singh brothers from selling assets till Fortis dues are cleared

      SEBI bars Singh brothers from selling assets till Fortis dues are cleared

      Meghna A Singhania20 March 2019 11:48 AM IST
      Singh brothers and the six entities have also been directed not to dispose of any of their assets or divert any funds without Sebi's prior permission,...
      Fake Meningitis Vaccine Racket: Jodhpur Paediatrician under drug controller lens

      Fake Meningitis Vaccine Racket: Jodhpur Paediatrician under drug controller lens

      Meghna A Singhania19 March 2019 5:57 PM IST
      Talking about the seize, Phatak said, “The supplier of the vaccine is the same Jodhpur-based paediatrician, who is authorised stockist of the company...
      Raids in Rajasthan: Drug controller seizes bogus Meningitis vaccines

      Raids in Rajasthan: Drug controller seizes bogus Meningitis vaccines

      Meghna A Singhania18 March 2019 3:47 PM IST
      “It was enough for us to doubt on it as how a shopkeeper buys a product in higher rates and selling it at lesser prices. We are investigating into the...
      Union Health Ministry blocking Juul e cigarettes from coming into country: Report

      Union Health Ministry blocking Juul e cigarettes from coming into country: Report

      Meghna A Singhania18 March 2019 12:42 PM IST
      "Novel products such as 'Juul' are harmful and addictive and could potentially undermine our tobacco control efforts," Health Secretary Preeti Sudan...
      Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

      Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

      Meghna A Singhania17 March 2019 1:33 PM IST
      New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok